Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 May;78(5):1027-1037.
doi: 10.1002/jpn3.12194. Epub 2024 Apr 1.

Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study

Florian Koutny  1   2 , Dagobert Wiemann  3 , Alexander Eckert  4 , Svenja Meyhöfer  5   6   7 , Maria Fritsch  8 , Angeliki Pappa  9 , Susanna Wiegand  10 , Marc Weyer  11 , Michael Wurm  12 , Daniel Weghuber  1 , Reinhard W Holl  4
Affiliations
Observational Study

Poorly controlled pediatric type 1 diabetes mellitus is a risk factor for metabolic dysfunction associated steatotic liver disease (MASLD): An observational study

Florian Koutny et al. J Pediatr Gastroenterol Nutr. 2024 May.

Abstract

Objectives: Recent studies have suggested a link between type 1 diabetes mellitus (T1D) and metabolic dysfunction associated steatotic liver disease (MASLD) in children and adolescent, but longitudinal evidence is lacking. This study aimed to investigate the potential association between poorly controlled T1D and elevated alanine aminotransferase (ALT), serving as a proxy for MASLD in children and adolescents over time.

Methods: The study included 32,325 children aged 2-17 years with T1D from Germany, Austria, and Switzerland who had undergone at least one assessment of liver enzyme levels recorded in the Diabetes-Patienten- Verlaufsdokumentation registry. Multivariable logistic and Cox regression models were calculated to show possible associations between T1D and elevated ALT values (>26 U/L in males, >22 U/L in females) as a proxy for MASLD.

Results: Children with poorly controlled T1D (HbA1c > 11%) exhibited increased odds of elevated ALT values, after adjustment for age, sex, diabetes duration and overweight (odds ratio [OR] 2.54; 95% confidence interval [CI], 2.10-3.10; p < 0.01). This finding is substantiated by a longitudinal analysis, which reveals that inadequately controlled T1D was associated with a higher hazard ratio (HR) of elevated ALT values compared to children with controlled T1D over an observation period extending up to 5.5 (HR: 1.54; 95% CI, 1.19-2.01; p < 0.01).

Conclusion: In conclusion, the current study strongly links poorly controlled T1D in children and adolescents to MASLD irrespective of overweight. This association is not only present cross-sectionally but also increases over time. The study underscores the critical role of effective diabetes management in reducing the risk of MASLD in this population.

Keywords: glucagon‐like peptide; liver fibrosis; metabolic syndrome; overweight; transaminases.

PubMed Disclaimer

References

REFERENCES

    1. Meyhöfer S, Eckert AJ, Hummel M, et al. Elevated liver enzymes and comorbidities in type 2 diabetes: a multicentre analysis of 51 645 patients from the diabetes prospective follow‐up (DPV) database. Diabet Obes Metab. 2022;24(4):727‐732. doi:10.1111/dom.14616
    1. Newton KP, Hou J, Crimmins NA, et al. Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease. JAMA Pediatrics. 2016;170(10):e161971. doi:10.1001/jamapediatrics.2016.1971
    1. Koutny F, Stein R, Kiess W, Weghuber D, Körner A. Elevated transaminases potentiate the risk for emerging dysglycemia in children with overweight and obesity. Pediatric Obesity. 2021;16(12):e12822. doi:10.1111/ijpo.12822
    1. Koutny F, Weghuber D, Bollow E, et al. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in european German‐speaking countries. Analysis of the APV initiative. Pediatric Obesity. 2020;15(4):e12601. doi:10.1111/ijpo.12601
    1. Vendhan R, Amutha A, Anjana RM, Unnikrishnan R, Mohan V. Clinical profile of nonalcoholic fatty liver disease among young patients with type 1 diabetes mellitus seen at a diabetes speciality center in India. Endocrine Practice. 2014;20(12):1249‐1257. doi:10.4158/EP14044.OR

Publication types

Substances

LinkOut - more resources